Patent application number | Description | Published |
20090310706 | Transmitter and Receiver Using Pseudo-Orthogonal Code - A transmitter using pseudo-orthogonal code includes a serial-to-parallel converter for converting serial transmission data into 9-bit parallel data, and a pseudo-orthogonal code memory for receiving the parallel data from the serial-to-parallel converter and outputting 16-bit pseudo-orthogonal code by using the received data as addresses. The pseudo-orthogonal code memory has the relationship of the input address and output code, as expressed in the following equation: | 12-17-2009 |
20110103249 | METHOD AND APPARATUS FOR MEASURING CELL IN A WIRELESS COMMUNICATION SYSTEM - A method and apparatus for measuring a cell a wireless communication system are disclosed. The method includes receiving measurement configuration information for a plurality of frequencies from a BS, without a dedicated connection between a UE and a network, and measuring cells using the plurality of frequencies according to the measurement configuration information. | 05-05-2011 |
20110103326 | METHOD OF OPERATING USER EQUIPMENT IN WIRELESS COMMUNICATION SYSTEM USING A PLURALITY OF UPLINK FREQUENCIES - A method of operating a user equipment in a wireless communication system using a plurality of uplink frequencies is disclosed. The method of operating the user equipment in the wireless communication system using the plurality of uplink frequencies includes identifying deactivation of a specific uplink frequency among the plurality of uplink frequencies, and flushing a Hybrid Automatic Repeat reQuest (HARQ) process associated with the specific uplink frequency. | 05-05-2011 |
20110244902 | METHOD AND APPARATUS FOR HANDLING BARRED CELL IN WIRELESS COMMUNICATION SYSTEM - A method of handling a barred cell in a wireless communication system is disclosed. The method of handling a barred cell in a user equipment using a plurality of frequencies includes releasing a Radio Resource Control (RRC) connection between the user equipment and a network if authentication between the user equipment and the network fails, and regarding a cell having a first uplink radio link and a first downlink radio link, a cell having only a second uplink radio link and a cell having only a second downlink radio link as barred cells, if the RRC connection is released. | 10-06-2011 |
20120039471 | EFFICIENT SECURITY-RELATED PROCESSING - An efficient security related procedure is disclosed. A plurality of service data units (SDUs) having the same priority is multiplexed to one unit signal. The unit signal is ciphered using a mask generated by a first parameter combination. The receiver simultaneously deciphers the multiplexed service data units (SDUs), such that a Layer- | 02-16-2012 |
Patent application number | Description | Published |
20090175173 | METHOD OF HANDLING AN ERROR ON CS VOICE OVER HSPA - A method of processing data at a specific protocol layer in a wireless communication system is disclosed. The present invention includes the steps of receiving a first data block including sequence information from a lower layer, checking a status of a second data block contained in the first data block, the second data block being an upper layer data block having time information, and if the status of the second data block fails to correspond to a prescribed condition, discarding the first data block. | 07-09-2009 |
20090196230 | METHOD FOR CONTROLLING UPLINK LOAD IN CELL_FACH STATE - A method for a user equipment (UE) to perform uplink re-access in a wireless communication system is provided. The method includes performing an uplink access procedure to establish a data transmission channel, checking whether or not the data transmission channel has been released, and delaying uplink re-access to the data transmission channel by a wait time when the data transmission channel has been released. | 08-06-2009 |
20100188969 | SIGNAL TRANSMISSION SCHEME FOR EFFICIENT MANAGEMENT OF COMMON ENHANCED DEDICATED CHANNEL - A signal transmission scheme for efficient management of a common E-DCH is provided. In the case of a common E-DCH that a UE in an idle mode or in a CELL_FACH status uses within a limited period of time, the UE may notify a Node B of release of radio resources of the common E-DCH using scheduling information including TEBS=0 within the period of time when the UE has completed data transmission. It is possible to prevent unnecessary waste of resources and unnecessary battery consumption of the UE by taking into consideration the above circumstances when triggering new scheduling information since HARQ transmission of the scheduling information has failed. | 07-29-2010 |
20110044297 | APPARATUS AND METHOD OF TRANSMITTING DATA BLOCK ON UPLINK FREQUENCIES - A method and apparatus of generating a data block for a plurality of uplink frequencies is provided. The apparatus determines a size of a data field of the data block so that each data block matches a minimum of a first amount of data and second amount of data. The first amount of data is allowed to be transmitted by a first grant on a first uplink frequency and the second amount of data is allowed to be transmitted by a second grant on a second uplink frequency. The apparatus generates at least one data block so that the amount of data in the generated data blocks is less than multiple times the minimum of the first amount of data and the second amount of data. | 02-24-2011 |
20110171989 | METHOD AND APPARATUS OF POWER INCREASE/DECREASE REQUEST OF A USER EQUIPMENT USING A PLURALITY OF FREQUENCIES IN A WIRELESS COMMUNICATION SYSTEM - A method of a power increase/decrease request of a user equipment in a wireless communication system using a plurality of frequencies is disclosed. The method of operating of a user equipment comprises receiving grants for each of the plurality of uplink frequencies from a base station; dividing a maximum power of the user equipment for each of the plurality of uplink frequencies in accordance with the received grants, and selecting a corresponding transport block for each of the plurality of uplink frequencies by considering the received grants; and comparing a remaining power of the user equipment to a power obtained by subtracting a power required to transmit a first transport block selected for a first uplink frequency from a power required to transmit a minimum transport block, which transmits more data than those of the first transport block. | 07-14-2011 |
Patent application number | Description | Published |
20110130409 | SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[B]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS - The present invention relates to certain substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives of Formula (Ia) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1 receptor-associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, microbial infections or diseases and viral infections or diseases. | 06-02-2011 |
20110160243 | SUBSTITUTED TRICYCLIC ACID DERIVATIVES AS S1P1 RECEPTOR AGONISTS USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS - The present invention relates to certain substituted tricyclic acid derivatives of Formula (I) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1-associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, myocardial ischemia-reperfusion injury, hypertensive nephropathy, glomerulosclerosis, gastritis, polymyositis, thyroiditis, vitiligo, hepatitis, biliary cirrhosis, microbial infections and associated diseases, viral infections and associated diseases, diseases and disorders mediated by lymphocytes, auto immune diseases, inflammatory diseases, and cancer. | 06-30-2011 |
20130184307 | SUBSTITUTED TRICYCLIC ACID DERIVATIVES AS S1P1 RECEPTOR AGONISTS USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS - The present invention relates to certain substituted tricyclic acid derivatives of Formula (I) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. | 07-18-2013 |
20140038987 | SUBSTITUTED 1,2,3,4-TETRAHYDROCYCLOPENTA[b]INDOL-3-YL)ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS - The present invention relates to certain substituted 1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid derivatives of Formula (Ia) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1 receptor-associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, microbial infections or diseases and viral infections or diseases. | 02-06-2014 |
20140051629 | MODULATORS OF THE GPR119 RECEPTOR AND THE TREATMENT OF DISORDERS RELATED THERETO - The present invention relates to the GPR119 receptor agonists: 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)-N,N-dimethylbenzamide; -fluoro-4-(5-fluoro-6-(4-(3-(2-fluoro-propan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)-N-methylbenzamide; and 3-fluoro-4-(5-fluoro-6-(4-(3-(2-fluoropropan-2-yl)-1,2,4-oxadiazol-5-yl)piperidin-1-yl)pyrimidin-4-ylamino)benzamide, and pharmaceutically acceptable salts, solvates, and hydrates thereof, that are useful as a single pharmaceutical agent or in combination with one or more additional pharmaceutical agents, such as, a DPP-IV inhibitor, a biguanide, an alpha-glucosidase inhibitor, an insulin analogue, a sulfonylurea, an SGLT2 inhibitor, a meglitinide, a thiazolidinedione, or an anti-diabetic peptide analogue, in the treatment of for example, a disorder selected from: a GPR119-receptor-related disorder; a condition ameliorated by increasing secretion of an incretin; a condition ameliorated by increasing a blood incretin level; a condition characterized by low bone mass; a neurological disorder; a metabolic-related disorder; type 2 diabetes; obesity; and complications related thereto. | 02-20-2014 |
20140066369 | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto - The present invention relates to compounds of Formula I and pharmaceutically acceptable salts, solvates, and hydrates thereof, that are useful as single pharmaceutical agents or in combination with one or more additional pharmaceutical agents, such as, a DPP-IV inhibitor, a biguanide, an alpha-glucosidase inhibitor, an insulin analogue, a sulfonylurea, an SGLT2 inhibitor, a meglitinide, a thiazolidinedione, or an anti-diabetic peptide analogue, in the treatment of for example, a disorder selected from: a GPR119-receptor-related disorder; a condition ameliorated by increasing a blood incretin level; a condition characterized by low bone mass; a neurological disorder; a metabolic-related disorder; type 2 diabetes; obesity; and complications related thereto. | 03-06-2014 |